Telomir Pharmaceuticals (TELO) Institutional Ownership $2.59 +0.08 (+3.19%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$2.58 0.00 (-0.19%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$3.91MNumber ofInstitutional Sellers(last 12 months)0 Get TELO Insider Trade Alerts Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TELO Institutional Buying and Selling by Quarter Telomir Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2025 Bank of New York Mellon Corp91,353$295K0.0%+26.4%0.307% 2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036% 2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023% 2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049% 2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510% 2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097% 2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101% 2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034% 2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390% 2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139% 2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032% 2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050% 2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157% 2/4/2025 Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244% 1/30/2025 Rhumbline Advisers8,600$35K0.0%+105.9%0.029% 11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806% 11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122% 10/21/2024 Suncoast Equity Management51,194$329K0.0%+109.9%0.173% 8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049% 7/26/2024 Bank of New York Mellon Corp50,165$241K0.0%N/A0.169% 5/2/2024 Suncoast Equity Management24,391$126K0.0%N/A0.082% (Data available from 1/1/2016 forward) TELO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TELO shares? During the previous two years, 18 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($295K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on TELO's institutional investors. Which institutional investors have been buying Telomir Pharmaceuticals stock? Of the 18 institutional investors that purchased Telomir Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Suncoast Equity Management ($51.19K), JPMorgan Chase & Co. ($37.98K), Charles Schwab Investment Management Inc. ($35.56K), and Barclays PLC ($33.68K). How much institutional buying is happening at Telomir Pharmaceuticals? Institutional investors have bought a total of 840,737 shares in the last 24 months. This purchase volume represents approximately $4.04M in transactions. Related Companies Atai Life Sciences Major Shareholders MBX Biosciences Major Shareholders Palvella Therapeutics Major Shareholders Monte Rosa Therapeutics Major Shareholders Cartesian Therapeutics Major Shareholders Aura Biosciences Major Shareholders Phathom Pharmaceuticals Major Shareholders Cryoport Major Shareholders iTeos Therapeutics Major Shareholders Septerna Major Shareholders This page (NASDAQ:TELO) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELO Stock Free TELO Stock Alerts